NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Completed a technology transfer, submitted a new manufacturing file to the United States ("U.S.") Food and Drug Administration ("FDA"), and released new drug...
Source: prnewswire.com